The American College of Rheumatology has issued clinical guidance to rheumatology providers for the management of pediatric patients with rheumatic disease during the COVID-19 pandemic.
Researchers evaluated the prevalence of hospital-diagnosed COVID-19 in chronic inflammatory and autoimmune rheumatic diseases.
Researchers determined the effect of treatment with cyclophosphamide and mycophenolate mofetil on patient-reported outcomes in systemic sclerosis-related interstitial lung disease.
Researchers evaluated anticentromere and -topoisomerase antibody-specific isotype expression and organ involvement associated with the degree of microangiopathy in systemic sclerosis.
Authors of this viewpoint described the current challenges in the management of cytokine storm syndromes and reviewed the safety profile of intravenous anakinra.
A EULAR task force developed recommendations for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy.
Researchers evaluated the association between trabecular bone score and new bone formation in ankylosing spondylitis.
Researchers described the frequency of rheumatic regional pain syndromes in first-degree relatives of patients with rheumatoid arthritis.
Researchers compared the 3 diagnostic criteria and assessed the performance of an additional set of criteria in the diagnosis of fibromyalgia.
An increase in hospitalizations for acute myocardial infarction-rheumatoid arthritis was observed between 2002 and 2016, with rheumatoid arthritis found to be independently associated with lower in-hospital mortality in patients with acute myocardial infarction.
